22-05-2013

Malvern Instruments has announced an agreement with Proveris Scientific Corporation to provide a complete solution for nasal spray characterization. This solution comprises the SoloTM for Spraytec system (Proveris), a patented automated actuator and software for the control of the actuation ...

more

16-05-2013

OPX Biotechnologies, Inc. (OPXBIO) and Evonik Industries AG announced the two companies have entered into an agreement to jointly develop certain bio-based specialty chemicals. The joint-development agreement signed May 3rd 2013 calls for OPXBIO to use its proprietary EDGE™ (Efficiency ...

more

03-05-2013

Oxford BioMedica plc announced that it has signed an agreement with Novartis to manufacture clinical grade material utilising Oxford BioMedica’s LentiVector® gene delivery technology. Under the terms of the agreement, Oxford BioMedica will also provide certain process development services ...

more

02-05-2013

The Belfer Institute for Applied Cancer Science at Dana-Farber Cancer Institute and Evotec AG (EVT) announced a research collaboration aimed at discovering and commercialising novel cancer treatments based on epigenetic drug mechanisms. The goal of the collaboration is to validate emerging ...

more

First Innovation Alliance to receive approval letter

06-03-2013

As the industrial coordinator of the innovation alliance, the biotechnology company BRAIN AG has announced that the Natural Life Excellence Network 2020 (NatLifE 2020) innovation alliance is the first alliance to receive the official approval letter under the “Industrial Biotechnology ...

more

27-02-2013

4SC AG announced that its fully-owned research subsidiary 4SC Discovery GmbH has entered into an exclusive research and license agreement with LEO Pharma A/S, Ballerup, Denmark with the primary aim of jointly researching, developing and commercialising an oral treatment for inflammatory skin ...

more

27-02-2013

Researchers from the Department of Life Sciences and the National Institute for Biotechnology in the Negev at Ben-Gurion University of the Negev in collaboration with Teva pharmaceutical industries LTD. have engineered a natural immune system receptor into a promising drug candidate for the ...

more

26-02-2013

Ablynx and Spirogen Ltd. announced a research collaboration to evaluate the potential of a novel anti-cancer drug conjugate combining Spirogen's proprietary cytotoxic drugs, pyrrolobenzodiazepines (PBD), and associated linker technology, with Nanobodies® generated using Ablynx’s proprietary ...

more

15-02-2013

The European Lead Factory, a novel platform for innovative drug discovery, was launched early February by an international consortium of 30 partners including the Lead Discovery Center GmbH (LDC). LDC is an expert in the discovery and generation of small molecule lead series by translating ...

more

31-01-2013

Evolva Holding SA announced that it has achieved a key milestone in its collaboration with BASF. The collaboration involves joint research on the design of novel and optimised biosynthetic routes for a natural product with crop protectionpotential. Evolva has produced a yeast strain that ...

more